Roger H. Giller

Hematology | Oncology

13123 E 16th Ave
Aurora, CO 80045

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities.

The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities.

Journal: Transplantation and cellular therapy

Published: March 07, 2024

Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD.

Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD.

Journal: Bone marrow transplantation

Published: August 07, 2023

Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events.

Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events.

Journal: Blood

Published: February 09, 2023

High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia.

High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia.

Journal: Blood advances

Published: May 17, 2021

Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation.

Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation.

Journal: Blood advances

Published: May 10, 2021

A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study.

A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study.

Journal: Pediatric blood & cancer

Published: February 20, 2021

Incorporating genetic counseling into the evaluation of pediatric bone marrow failure.

Incorporating genetic counseling into the evaluation of pediatric bone marrow failure.

Journal: Journal of genetic counseling

Published: January 23, 2021

Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.

Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 15, 2021

An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients: Revaccination Outcomes Following Pediatric HSCT.

An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients: Revaccination Outcomes Following Pediatric HSCT.

Journal: Transplantation and cellular therapy

Published: November 16, 2020

Glycemic variability is associated with poor outcomes in pediatric hematopoietic stem cell transplant patients.

Glycemic variability is associated with poor outcomes in pediatric hematopoietic stem cell transplant patients.

Journal: Pediatric blood & cancer

Published: May 13, 2020

Autoimmune cytopenias following allogeneic hematopoietic stem cell transplant in pediatric patients: Response to therapy and late effects.

Autoimmune cytopenias following allogeneic hematopoietic stem cell transplant in pediatric patients: Response to therapy and late effects.

Journal: Pediatric blood & cancer

Published: April 28, 2020

Safety and Accuracy of Factory-Calibrated Continuous Glucose Monitoring in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation.

Safety and Accuracy of Factory-Calibrated Continuous Glucose Monitoring in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation.

Journal: Diabetes technology & therapeutics

Published: February 28, 2020

Showing 1-12 of 29

Last Updated: 09/26/2026